Marksans Pharma Limited (MARKSANS.NS) NSE
241.19
+2.51(+1.05%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
241.19
+2.51(+1.05%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1141
First IPO Date
July 19, 2002
| Name | Title | Pay | Year Born |
| Varddhman Vikramaditya Jain | Whole-Time Executive Non Independent Director | 23.98M | 1970 |
| Sandra Saldanha | Whole-Time Executive Non Independent Director | 23.98M | 1971 |
| Mark Saldanha | Non-Independent Executive Chairman & MD | 63.76M | 1972 |
| Anjani Kumar | Chief Operating Officer of US Operations | 0 | 1961 |
| David Mohammed | Managing Director of Australia Operations | 0 | N/A |
| Harshavardhan Panigrahi | Company Secretary, Manager of Legal & Compliance Officer | 0 | N/A |
| Jitendra Sharma | Group Chief Financial Officer | 0 | 1969 |
| Sathish Kumar | Managing Director of UK Operations | 0 | N/A |
| Sunil K. Rane | Senior Vice President of QC | 0 | 1969 |
| Vishal Bhargava | Director Operations | 0 | 1971 |
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.